Claustrum Hyperintensity as a Marker of Anti-NMDA-Receptor Antibody Encephalitis.

MLA

Datta, Amlan K., et al. “Claustrum Hyperintensity as a Marker of Anti-NMDA-Receptor Antibody Encephalitis.” Neurology India, vol. 70, no. 5, Sept. 2022, pp. 2290–91. EBSCOhost, https://doi.org/10.4103/0028-3886.359170.

APA

Datta, A. K., Dutta, A., Malakar, S., & Pandit, A. (2022). Claustrum Hyperintensity as a Marker of Anti-NMDA-Receptor Antibody Encephalitis. Neurology India, 70(5), 2290–2291. https://doi.org/10.4103/0028-3886.359170

Chicago

Datta, Amlan K, Arpan Dutta, Sudeshna Malakar, and Alak Pandit. 2022. “Claustrum Hyperintensity as a Marker of Anti-NMDA-Receptor Antibody Encephalitis.” Neurology India 70 (5): 2290–91. doi:10.4103/0028-3886.359170.